Panama’s Ministry of Health has officially approved the registration forms for medicinal cannabis patients. The new system requires all users to enroll in a digital platform managed by the government. This marks a major step in implementing the country’s Panama medicinal cannabis law.
The resolution, numbered 0416 and dated May 12, 2026, comes from the General Directorate of Public Health. It was published recently in the Official Gazette. The document approves specific forms and medical certifications needed for patient registration and authorized companion enrollment. Health officials consider this a critical step toward full implementation of Law 242 from October 2021, which regulates medicinal and therapeutic cannabis use in Panama.
Patients must now register in the System for the Identification of Medicinal Cannabis Users and Authorized Companions, known as Siucmaa. This is a digital platform operated by the Panama Ministry of Health.
What Information Patients Must Provide
The registration form requires specific personal data. Patients must submit their full name, national identity number or passport, date of birth, residential address, and contact information. The document also asks for details about the treating physician. Medical conditions justifying the treatment must be included along with the authorization for medicinal cannabis use.
A medical certification must support every registration. That certification must come from a professional recognized by the Technical Council of Public Health. The document needs to detail the patient’s diagnosis, therapeutic indication, recommended dosage, administration route, usage frequency, and estimated treatment duration. [Translated from Spanish]
Companion Registration for Vulnerable Patients
The resolution also covers authorized companion registration. This applies when a patient’s condition requires assistance. It becomes especially relevant for minors, elderly adults, or people with disabilities who need ongoing support during treatment.
Health authorities explained the goal clearly. These mechanisms ensure traceability, control, and supervision of cannabis-derived products used for medical purposes. The system prevents misuse and strengthens health surveillance. [Translated from Spanish]
Medical Conditions Eligible for Treatment
Law 242 establishes that medicinal cannabis can serve as a therapeutic alternative. The key requirement is scientific evidence and medical criteria supporting its use. Common conditions include refractory epilepsy resistant to conventional drugs, chronic pain that is difficult to manage, multiple sclerosis, and various neurological diseases.
Cancer patients and those undergoing oncology treatments may also qualify. Symptoms like nausea, vomiting, appetite loss, and persistent pain can be treated. Some countries prescribe cannabis for terminal illness patients or those with conditions severely affecting quality of life.
Access is not automatic. Each case requires a doctor’s evaluation. The physician determines if treatment is appropriate and meets legal requirements. The medicinal cannabis regulation framework in Panama follows international standards for patient safety.
Gradual Implementation Since Legalization
These forms represent one of the most concrete advances in launching the National Program for the Study and Medicinal Use of Cannabis and its Derivatives. This program coordinates research, regulation, and monitoring of these treatments. Medicinal cannabis has had legal backing since 2021. Administrative procedures have advanced gradually. With these documents approved, the Ministry of Health aims to make the registration and monitoring system fully operational for patients seeking this therapeutic alternative under medical supervision.
The Public Health system continues to adapt to new treatment modalities. Officials stress that patient safety remains the top priority throughout this process.